Mass & Weight Set Calibration for Pharmaceutical & GMP Laboratories

Under FDA 21 CFR Part 211 (cGMP for pharmaceuticals) and 21 CFR Part 58 (GLP), calibration weight sets used in drug manufacturing and testing must have: (1) current calibration certificates with NIST traceability and documented measurement uncertainty; (2) calibration intervals established and justified in writing; (3) as-found data at each recertification (to support change control if the weight is found out of tolerance); and (4) documented procedures for handling out-of-tolerance findings, including impact assessment for balance calibrations performed with the weight since the last recertification. Femto Scientific’s ISO 17025 accredited certificates deliver all required documentation in electronic format for GMP QMS integration.

Pharmaceutical laboratories most commonly use ASTM Class 1 and Class 2 weight sets (or their OIML equivalents, E2 and F1) for analytical balance calibration and instrument qualification. ASTM Class 1 is used for semi-micro and microbalance programs where balances have readabilities of 0.01 mg or better. ASTM Class 2 covers most analytical balance programs (0.1 mg readability) used in pharmaceutical QC, compounding, and testing. Precision balance programs (1 mg readability and above) may use Class 3 or Class 4 weights. All classes used in pharmaceutical GMP environments must have current, NIST-traceable ISO/IEC 17025 accredited calibration certificates.

FDA does not explicitly mandate ISO 17025 accreditation in 21 CFR regulations, but FDA guidance and inspection expectations increasingly reflect the ISO 17025 standard as the appropriate framework for laboratory equipment calibration documentation. FDA inspectors evaluating calibration records for GMP compliance look for NIST traceability, documented measurement uncertainty, as-found and as-left data, and evidence of technical competency — all of which are verified by ISO 17025 accreditation. Femto Scientific’s ISO/IEC 17025 accredited weight calibration certificates have been accepted by FDA inspectors at pharmaceutical manufacturing facilities for equipment qualification documentation.

Measurement uncertainty in mass calibration quantifies the range of values within which the true conventional mass of the weight lies, at a stated confidence level (typically 95%). It combines contributions from reference weight uncertainty, mass comparator repeatability and resolution, buoyancy correction uncertainty, temperature effects, and other sources. ISO/IEC 17025 accredited certificates report expanded uncertainty (U, k=2), which represents approximately 95% confidence. This value must be smaller than the applicable ASTM or OIML class tolerance to confirm that the calibration can distinguish between a passing and failing weight.

As-found data documents the weight’s conventional mass value before any cleaning, handling, or adjustment during the recertification visit — representing the weight’s actual condition as it was being used in your laboratory. As-left data documents the final calibrated mass value after cleaning and any allowable adjustment, representing the weight’s condition when returned to service. Both datasets together provide the before/after documentation required by GMP change control programs, CAP inspection checklists, and equipment qualification protocols. An out-of-tolerance as-found finding triggers an impact assessment for balance calibrations performed since the previous recertification.